Vanguard Fiduciary Trust
PLYX

Vanguard Fiduciary Trust’s Polaryx Therapeutics Inc PLYX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
105,072
+516
+0.5% +$2.02K ﹤0.01% 3467
2026
Q1 		$790K Buy
+104,556
New +$675K ﹤0.01% 3024

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Fiduciary Trust's PLYX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Polaryx Therapeutics Inc (PLYX) stake by 0.49% in Q2 2026, buying an estimated $2.02K and bringing the position to 105,072 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.

Vanguard Fiduciary Trust first reported a position in PLYX in Q1 2026 and has held it in 2 quarters since. The position peaked at $790K in Q1 2026. 13 funds tracked by Wall St. Rank hold PLYX as of Q2 2026.

  • Vanguard Fiduciary Trust held 105,072 shares of Polaryx Therapeutics Inc worth $279K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 516 Polaryx Therapeutics Inc shares in Q2 2026, an estimated $2.02K.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3467 holding.
  • Vanguard Fiduciary Trust first reported a position in Polaryx Therapeutics Inc in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Polaryx Therapeutics Inc position peaked at $790K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.